Open AccessP1278: ACTIVATION OF THE NECROPTOSIS PATHWAY PLAYS A ROLE IN SYNERGISM WITH COMBINATION OF THE IAP ANTAGONIST, TOLINAPANT AND HYPOMETHYLATING AGENTS (HMA) IN IN VITRO MODELS OF T‐CELL LYMPHOMA (TCL).
Author(s) -
Manavalan J. S.,
Pal I.,
Pursley A.,
Ward G.,
Smyth T.,
Sims M.,
Feith D.,
Loughran T. P.,
O'Connor O. A.,
Marchi E.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847976.26425.20
Subject(s) - necroptosis , programmed cell death , xiap , decitabine , cancer research , pharmacology , apoptosis , azacitidine , medicine , chemistry , caspase , biochemistry , gene expression , dna methylation , gene